share_log

Mission Produce, Nvidia, Humacyte, BlackBerry And Other Big Stocks Moving Higher On Friday

Mission Produce, Nvidia, Humacyte, BlackBerry And Other Big Stocks Moving Higher On Friday

Mission Produce, 英偉達, Humacyte, 黑莓 和 其他 大 股票 在週五上漲
Benzinga ·  12/20 23:50

U.S. stocks were higher, with the Dow Jones index gaining over 300 points on Friday.

美國股市上漲,道瓊斯指數週五上漲超過300點。

Shares of Mission Produce, Inc. (NASDAQ:AVO) rose sharply during today's session after the company reported better-than-expected fourth-quarter sales results.

Mission Produce, Inc.(納斯達克股票代碼:AVO)的股價在今天的交易中大幅上漲,此前該公司公佈的第四季度銷售業績好於預期。

Mission Produce reported quarterly earnings of 28 cents per share and quarterly revenue of $354.4 million, which beat the analyst consensus estimate of $220.4 million.

Mission Produce公佈的季度每股收益爲28美分,季度收入爲3.544億美元,超過了分析師共識估計的2.204億美元。

Mission Produce shares jumped 22.3% to $15.07 on Friday.

週五,Mission Produce股價上漲22.3%,至15.07美元。

Here are some other big stocks recording gains in today's session.

以下是其他一些在今天的交易日中錄得漲幅的大型股票。

  • Humacyte, Inc. (NASDAQ:HUMA) shares jumped 55.2% to $5.37 after the company announced FDA approval for SYMVESS for treating extremity vascular injuries. HC Wainwright & Co. raised its price target on the stock from $12 to $15.
  • Personalis, Inc. (NASDAQ:PSNL) gained 32% to $6.94 after the company and Moderna recently announced a multi-year extension to continue utilizing the Personalis ImmunoID NeXT platform and technology for V940/mRNA-4157. The company also announced an investment from Merck.
  • Enovix Corporation (NASDAQ:ENVX) gained 22% to $9.80 as the company shipped first EX-2M samples to mobile phone customers.
  • Clearwater Paper Corporation (NYSE:CLW) surged 21.2% to $29.96.
  • Rigetti Computing, Inc. (NASDAQ:RGTI) gained 20.2% to $8.99.
  • Quantum Computing Inc. (NASDAQ:QUBT) gained 20% to $18.17. In an exchange filing dated December 20, Quantum Computing has registered up to 8.96 million shares for resale by selling stockholders.
  • BlackBerry Limited (NYSE:BB) surged 20% to $3.58 as the company posted upbeat quarterly earnings.
  • IonQ, Inc. (NYSE:IONQ) gained 15.5% to $ 43.63. Craig-Hallum analyst Richard Shannon maintained IonQ with a Buy and raised the price target from $22 to $45.
  • Sirius XM Holdings Inc. (NASDAQ:SIRI) rose 10% to $22.59. Warren Buffett acquired 4.96 million Sirius XM shares at an average price of $21.60.
  • Plug Power Inc. (NASDAQ:PLUG) gained 9.7% to $2.5248.
  • Lucid Group, Inc. (NASDAQ:LCID) rose 9% to $2.8650.
  • Rivian Automotive, Inc. (NASDAQ:RIVN) gained 6.6% to $13.93.
  • Occidental Petroleum Corporation (NYSE:OXY) gained 4.7% to $47.47 after Berkshire Hathaway increased its stake in the company.
  • NVIDIA Corporation (NASDAQ:NVDA) rose 2.1% to $133.38. The European Commission on Thursday announced it approved the proposed acquisition of Run:ai Labs by NVIDIA.
  • Humacyte, Inc.(納斯達克股票代碼:HUMA)股價上漲55.2%,至5.37美元,此前該公司宣佈美國食品藥品管理局批准SYMVESS用於治療四肢血管損傷。HC Wainwright & Co. 將該股的目標股價從12美元上調至15美元。
  • Personalis, Inc.(納斯達克股票代碼:PSNL)上漲32%,至6.94美元,此前該公司和Moderna最近宣佈將Personalis Immunoid NeXT平台和技術繼續用於v940/mRNA-4157的期限延長多年。該公司還宣佈了默沙東的投資。
  • Enovix公司(納斯達克股票代碼:ENVX)上漲22%,至9.80美元,原因是該公司向手機客戶運送了第一批EX-200萬樣品。
  • 克利爾沃特紙業公司(紐約證券交易所代碼:CLW)上漲21.2%,至29.96美元。
  • Rigetti Computing, Inc.(納斯達克股票代碼:RGTI)上漲20.2%,至8.99美元。
  • 量子計算公司(納斯達克股票代碼:QUBT)上漲20%,至18.17美元。在12月20日提交的交易所文件中,量子計算已註冊多達896萬股股票供出售股東轉售。
  • 黑莓有限公司(紐約證券交易所代碼:BB)上漲20%,至3.58美元,原因是該公司公佈了樂觀的季度收益。
  • IonQ, Inc.(紐約證券交易所代碼:IONQ)上漲15.5%,至43.63美元。Craig-Hallum分析師理查德·香農維持了IonQ的買入並將目標股價從22美元上調至45美元。
  • Sirius Xm Holdings Inc.(納斯達克股票代碼:SIRI)上漲10%,至22.59美元。禾倫·巴菲特以21.60美元的平均價格收購了496萬股Sirius Xm股票。
  • Plug Power Inc.(納斯達克股票代碼:PLUG)上漲9.7%,至2.5248美元。
  • Lucid Group, Inc.(納斯達克股票代碼:LCID)上漲9%,至2.8650美元。
  • Rivian Automotive, Inc.(納斯達克股票代碼:RIVN)上漲6.6%,至13.93美元。
  • 伯克希爾·哈撒韋公司增加其在西方石油公司的股份後,西方石油公司(紐約證券交易所代碼:OXY)上漲4.7%,至47.47美元。
  • 英偉達公司(納斯達克股票代碼:NVDA)上漲2.1%,至133.38美元。歐盟委員會週四宣佈,它批准了英偉達收購Run: AI Labs的提議。

Now Read This:

現在閱讀這篇文章:

  • Top 3 Risk Off Stocks That May Collapse This Month
  • 本月可能暴跌的三大風險股票
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論